ZJYL (Jin Medical International) Research & Development: $1.56 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ZJYL Jin Medical International Ltd ZJYL
64 GF Score
Price $1.96
GF Value $14.58
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Jin Medical International Research & Development?

Jin Medical International ZJYL 64 Research & Development is $1.56 Mil as of Sep. 2025. GuruFocus rates ZJYL with a GF Score™ of 64/100 and a GF Value™ of $14.58 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Jin Medical International's Research & Development for the six months ended in Sep. 2025 was $0.90 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was $1.56 Mil.

Jin Medical International  (NAS:ZJYL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Jin Medical International Research & Development Related Terms

Jin Medical International Research & Development Historical Data

* Premium members only.

The historical data trend for Jin Medical International's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jin Medical International Research & Development Chart

Jin Medical International Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial 1.57 1.89 1.54 1.50 1.56

Jin Medical International Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.91 0.61 0.89 0.66 0.90
ZJYL
64GF Score
Jin Medical International Ltd ZJYL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jin Medical International Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $1.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $1.56 Mil mean?
Jin Medical International (ZJYL) has a Research & Development of $1.56 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on Jin Medical International and its competitors.
Is Jin Medical International's Research & Development too high?
Jin Medical International's current Research & Development is $1.56 Mil. Overall, Jin Medical International has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jin Medical International's Research & Development compare to RVP and CUPR?
Jin Medical International's Research & Development of $1.56 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Jin Medical International and its competitors. Jin Medical International's current Research & Development is $1.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jin Medical International stock overvalued right now?
Based on GuruFocus' analysis, Jin Medical International (ZJYL) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.58, compared to a current price of $1.96 — trading 86.6% below its estimated fair value. The current Research & Development is $1.56 Mil. Jin Medical International's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Jin Medical International (ZJYL), the current Research & Development is $1.56 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jin Medical International (ZJYL) Overvalued in 2026?

Based on GuruFocus' analysis, Jin Medical International stock appears to be undervalued. The current stock price of $1.96 is trading 86.6% below its estimated GF Value™ of $14.58. GuruFocus considers Jin Medical International to be Significantly Undervalued.

Key valuation signals for ZJYL:

  • Research & Development: $1.56 Mil
  • GF Value™: $14.58 vs. price of $1.96 (86.6% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the ZJYL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jin Medical International Business Description

Address No. 33 Lingxiang Road, Wujin District, Jiangsu Province, Changzhou, CHN
Jin Medical International Ltd, along with its subsidiaries, mainly offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other assistive living aid products for use by people with disabilities or impaired mobility. The group's product offering includes wheelchairs and wheelchair components, oxygen concentrators, bathing machines, respiratory and walking aids, oxygen chambers, beauty instruments, and nano products, among others. Wheelchairs are currently its key revenue-generating product. The products are sold to dealers in Japan and China, and to some extent to dealers located in the United States, Canada, Australia, Korea, Israel, Singapore, and other regions. Geographically, the group generates maximum revenue from Japan.
64GF Score

Get the complete analysis for ZJYL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.96
Price
$14.58
GF Value